Bioluminescent monitoring of NIS-mediated (131)I ablative effects in MCF-7 xenografts.
Optical imaging has made it possible to monitor response to anticancer therapies in tumor xenografts. The concept of treating breast cancers with (131)I is predicated on the expression of the Na(+)/I- symporter (NIS) in many tumors and uptake of I- in some. The pattern of (131)I radioablative effects were investigated in an MCF-7 xenograft model dually transfected with firefly luciferase and NIS genes. On Day 16 after tumor cell implantation, 3 mCi of (131)I was injected. Bioluminescent imaging using d-luciferin and a cooled charge-coupled device camera was carried out on Days 1, 2, 3, 7, 10, 16, 22, 29, and 35. Tumor bioluminescence decreased in (131)I-treated tumors after Day 3 and reached a nadir on Day 22. Conversely, bioluminescence steadily increased in controls and was 3.85-fold higher than in treated tumors on Day 22. Bioluminescence in (131)I-treated tumors increased after Day 22, corresponding to tumor regrowth. By Day 35, treated tumors were smaller and accumulated 33% less (99m)TcO(4)(-) than untreated tumors. NIS immunoreactivity was present in <50% of (131)I-treated cells compared to 85-90% of controls. In summary, a pattern of tumor regression occurring over the first three weeks after (131)I administration was observed in NIS-expressing breast cancer xenografts.
Ghosh
Malavika
M
Stanford University School of Medicine, Stanford, CA 94305, USA.
Gambhir
Sanjiv Sam
SS
De
Abhijit
A
Nowels
Kent
K
Goris
Michael
M
Wapnir
Irene
I
D000818:Animals; D045744:Cell Line, Tumor; D002999:Clone Cells; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D007457:Iodine Radioisotopes / Q000008:administration & dosage* / Q000627:therapeutic use; D008163:Luminescent Measurements; D008164:Luminescent Proteins / Q000096:biosynthesis; D008325:Mammary Neoplasms, Experimental / Q000378:metabolism / Q000473:pathology* / Q000532:radiotherapy*; D051379:Mice; D008819:Mice, Nude; D009368:Neoplasm Transplantation; D027981:Symporters / Q000502:physiology*; D014183:Transplantation, Heterologous; D000099209:Sodium-Iodide Symporters
D007457:Iodine Radioisotopes; D008164:Luminescent Proteins; D027981:Symporters; D000099209:Sodium-Iodide Symporters